Loading clinical trials...
Loading clinical trials...
The purpose of this registry is to acquire safety data (including assessment of anti-rHuPH20 antibodies), regarding the course and outcome of pregnancy in women ever treated with HYQVIA. Development o...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Baxalta now part of Shire
Collaborators
NCT06617650 · Maternal Exposure, Maternal Exposure During Pregnancy
NCT04108728 · HIV Infections, Exposure During Pregnancy, and more
NCT04493892 · Breast Cancer, Pregnancy Related, and more
NCT04492449 · Exposure During Pregnancy, Corona Virus Infection
NCT02337361 · Foetal Exposure During Pregnancy
QuintilesIMS Plaza Building
Durham, North Carolina
Fakultni nemocnice Kralovske Vinohrady
Prague
Freiburg University Hospital/ Prof. Dr. med. Bodo Grimbacher
Freiburg im Breisgau, Baden-Wurttemberg
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions